 | • レポートコード：MRC2-11QY05015 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は獣医感染症治療薬のグローバル市場について調査・分析したレポートです。種類別（抗生物質、抗ウイルス剤、抗真菌剤、殺菌剤、駆虫剤）市場規模、用途別（獣医病院、獣医クリニック、獣医薬局、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別獣医感染症治療薬の競争状況、市場シェア ・世界の獣医感染症治療薬市場：種類別市場規模 2015年-2020年（抗生物質、抗ウイルス剤、抗真菌剤、殺菌剤、駆虫剤） ・世界の獣医感染症治療薬市場：種類別市場規模予測 2021年-2026年（抗生物質、抗ウイルス剤、抗真菌剤、殺菌剤、駆虫剤） ・世界の獣医感染症治療薬市場：用途別市場規模 2015年-2020年（獣医病院、獣医クリニック、獣医薬局、研究所） ・世界の獣医感染症治療薬市場：用途別市場規模予測 2021年-2026年（獣医病院、獣医クリニック、獣医薬局、研究所） ・北米の獣医感染症治療薬市場分析：米国、カナダ ・ヨーロッパの獣医感染症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの獣医感染症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の獣医感染症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの獣医感染症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Elanco Animal Health、Novartis Animal Health、Merck、Pfizer Animal Health、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Veterinary Infectious Disease Therapeutics Market
The global Veterinary Infectious Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Veterinary Infectious Disease Therapeutics Scope and Market Size
Veterinary Infectious Disease Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Infectious Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Elanco Animal Health
Novartis Animal Health
Merck
Pfizer Animal Health
Sanofi
…
Market segment by Type, the product can be split into
Antibiotics
Antiviral
Antifungal
Amebicides
Anthelmintics
Market segment by Application, split into
Veterinary Hospitals
Veterinary Clinics
Veterinary Pharmacies
Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Veterinary Infectious Disease Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Veterinary Infectious Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotics
1.4.3 Antiviral
1.4.4 Antifungal
1.4.5 Amebicides
1.4.6 Anthelmintics
1.5 Market by Application
1.5.1 Global Veterinary Infectious Disease Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Veterinary Hospitals
1.5.3 Veterinary Clinics
1.5.4 Veterinary Pharmacies
1.5.5 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Infectious Disease Therapeutics Market Perspective (2015-2026)
2.2 Global Veterinary Infectious Disease Therapeutics Growth Trends by Regions
2.2.1 Veterinary Infectious Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Veterinary Infectious Disease Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Veterinary Infectious Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Veterinary Infectious Disease Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Veterinary Infectious Disease Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Infectious Disease Therapeutics Players by Market Size
3.1.1 Global Top Veterinary Infectious Disease Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Veterinary Infectious Disease Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Veterinary Infectious Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Veterinary Infectious Disease Therapeutics Market Concentration Ratio
3.2.1 Global Veterinary Infectious Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Veterinary Infectious Disease Therapeutics Revenue in 2019
3.3 Veterinary Infectious Disease Therapeutics Key Players Head office and Area Served
3.4 Key Players Veterinary Infectious Disease Therapeutics Product Solution and Service
3.5 Date of Enter into Veterinary Infectious Disease Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Veterinary Infectious Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Veterinary Infectious Disease Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020)
5.2 Global Veterinary Infectious Disease Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Veterinary Infectious Disease Therapeutics Market Size (2015-2020)
6.2 Veterinary Infectious Disease Therapeutics Key Players in North America (2019-2020)
6.3 North America Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020)
6.4 North America Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Veterinary Infectious Disease Therapeutics Market Size (2015-2020)
7.2 Veterinary Infectious Disease Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020)
7.4 Europe Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Veterinary Infectious Disease Therapeutics Market Size (2015-2020)
8.2 Veterinary Infectious Disease Therapeutics Key Players in China (2019-2020)
8.3 China Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020)
8.4 China Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Veterinary Infectious Disease Therapeutics Market Size (2015-2020)
9.2 Veterinary Infectious Disease Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020)
9.4 Japan Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Veterinary Infectious Disease Therapeutics Market Size (2015-2020)
10.2 Veterinary Infectious Disease Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Veterinary Infectious Disease Therapeutics Market Size (2015-2020)
11.2 Veterinary Infectious Disease Therapeutics Key Players in India (2019-2020)
11.3 India Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020)
11.4 India Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Veterinary Infectious Disease Therapeutics Market Size (2015-2020)
12.2 Veterinary Infectious Disease Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Elanco Animal Health
13.1.1 Elanco Animal Health Company Details
13.1.2 Elanco Animal Health Business Overview
13.1.3 Elanco Animal Health Veterinary Infectious Disease Therapeutics Introduction
13.1.4 Elanco Animal Health Revenue in Veterinary Infectious Disease Therapeutics Business (2015-2020))
13.1.5 Elanco Animal Health Recent Development
13.2 Novartis Animal Health
13.2.1 Novartis Animal Health Company Details
13.2.2 Novartis Animal Health Business Overview
13.2.3 Novartis Animal Health Veterinary Infectious Disease Therapeutics Introduction
13.2.4 Novartis Animal Health Revenue in Veterinary Infectious Disease Therapeutics Business (2015-2020)
13.2.5 Novartis Animal Health Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Veterinary Infectious Disease Therapeutics Introduction
13.3.4 Merck Revenue in Veterinary Infectious Disease Therapeutics Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Pfizer Animal Health
13.4.1 Pfizer Animal Health Company Details
13.4.2 Pfizer Animal Health Business Overview
13.4.3 Pfizer Animal Health Veterinary Infectious Disease Therapeutics Introduction
13.4.4 Pfizer Animal Health Revenue in Veterinary Infectious Disease Therapeutics Business (2015-2020)
13.4.5 Pfizer Animal Health Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Veterinary Infectious Disease Therapeutics Introduction
13.5.4 Sanofi Revenue in Veterinary Infectious Disease Therapeutics Business (2015-2020)
13.5.5 Sanofi Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Veterinary Infectious Disease Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Veterinary Infectious Disease Therapeutics Revenue
Table 3. Ranking of Global Top Veterinary Infectious Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Veterinary Infectious Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibiotics
Table 6. Key Players of Antiviral
Table 7. Key Players of Antifungal
Table 8. Key Players of Amebicides
Table 9. Key Players of Anthelmintics
Table 10. Global Veterinary Infectious Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Veterinary Infectious Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Veterinary Infectious Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Veterinary Infectious Disease Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Veterinary Infectious Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Veterinary Infectious Disease Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Veterinary Infectious Disease Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Veterinary Infectious Disease Therapeutics Players
Table 21. Global Veterinary Infectious Disease Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Veterinary Infectious Disease Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Veterinary Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Infectious Disease Therapeutics as of 2019)
Table 24. Global Veterinary Infectious Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Veterinary Infectious Disease Therapeutics Product Solution and Service
Table 27. Date of Enter into Veterinary Infectious Disease Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Veterinary Infectious Disease Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Veterinary Infectious Disease Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Veterinary Infectious Disease Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Veterinary Infectious Disease Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Veterinary Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Veterinary Infectious Disease Therapeutics Market Share (2019-2020)
Table 37. North America Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Veterinary Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 39. North America Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Veterinary Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Veterinary Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Veterinary Infectious Disease Therapeutics Market Share (2019-2020)
Table 43. Europe Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Veterinary Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Veterinary Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Veterinary Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Veterinary Infectious Disease Therapeutics Market Share (2019-2020)
Table 49. China Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Veterinary Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 51. China Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Veterinary Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Veterinary Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Veterinary Infectious Disease Therapeutics Market Share (2019-2020)
Table 55. Japan Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Veterinary Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Veterinary Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Veterinary Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Veterinary Infectious Disease Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Veterinary Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Veterinary Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Veterinary Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Veterinary Infectious Disease Therapeutics Market Share (2019-2020)
Table 67. India Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Veterinary Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 69. India Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Veterinary Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Veterinary Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Veterinary Infectious Disease Therapeutics Market Share (2019-2020)
Table 73. Central & South America Veterinary Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Veterinary Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Veterinary Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Veterinary Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 77. Elanco Animal Health Company Details
Table 78. Elanco Animal Health Business Overview
Table 79. Elanco Animal Health Product
Table 80. Elanco Animal Health Revenue in Veterinary Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 81. Elanco Animal Health Recent Development
Table 82. Novartis Animal Health Company Details
Table 83. Novartis Animal Health Business Overview
Table 84. Novartis Animal Health Product
Table 85. Novartis Animal Health Revenue in Veterinary Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 86. Novartis Animal Health Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Product
Table 90. Merck Revenue in Veterinary Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 91. Merck Recent Development
Table 92. Pfizer Animal Health Company Details
Table 93. Pfizer Animal Health Business Overview
Table 94. Pfizer Animal Health Product
Table 95. Pfizer Animal Health Revenue in Veterinary Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 96. Pfizer Animal Health Recent Development
Table 97. Sanofi Company Details
Table 98. Sanofi Business Overview
Table 99. Sanofi Product
Table 100. Sanofi Revenue in Veterinary Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 101. Sanofi Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Infectious Disease Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Antibiotics Features
Figure 3. Antiviral Features
Figure 4. Antifungal Features
Figure 5. Amebicides Features
Figure 6. Anthelmintics Features
Figure 7. Global Veterinary Infectious Disease Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Veterinary Hospitals Case Studies
Figure 9. Veterinary Clinics Case Studies
Figure 10. Veterinary Pharmacies Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Veterinary Infectious Disease Therapeutics Report Years Considered
Figure 13. Global Veterinary Infectious Disease Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Veterinary Infectious Disease Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Veterinary Infectious Disease Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Veterinary Infectious Disease Therapeutics Market Share by Players in 2019
Figure 18. Global Top Veterinary Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Infectious Disease Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Veterinary Infectious Disease Therapeutics Revenue in 2019
Figure 20. North America Veterinary Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Veterinary Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Veterinary Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Veterinary Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Veterinary Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Veterinary Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Veterinary Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
感染症治療薬の世界市場（～2026年） Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them. Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of in…- 感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…
- 獣医治療の世界市場（～2026年） Market Analysis and Insights: Global Veterinary Therapeutics Market The global Veterinary Therapeutics market size is projected to reach US$ 30990 million by 2026, from US$ 29770 million in 2020, at a CAGR of 3.8%% during 2021-2026. Global Veterinary Therapeutics Scope and Market Size Veterinary The…
- IVD感染症の世界市場（～2026年） In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.). Geographically, North America is the world's largest extracorporeal diagnostic market. Europe and the United S…
- 感染症検査における分子診断の世界市場（～2026年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …